UBS Group’s NeuroSense Therapeutics NRSN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.04K | Sell |
|
|||||
|
2025
Q1 | $2.12K | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $21.7K | Buy |
|
|||||
|
2023
Q4 | $4.31K | Sell |
|
|||||
|
2023
Q3 | $6.86K | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $8.19K | Buy |
|
|||||
|
2022
Q4 | $4.96K | Buy |
|
|||||
|
2022
Q3 | $3K | Sell |
|
|||||
|
2022
Q2 | $45K | Buy |
|
|||||
|
2022
Q1 | $7K | Sell |
|
|||||
|
2021
Q4 | $20K | Buy |
|